Probiotics to help non-organic digestive problems
Official title: Study on the Effect of Probiotics on Improving Gastrointestinal Function in Patients With Non-organic Gastrointestinal Dysfunction
Run by Wecare Probiotics Co., Ltd. · NCT07081100 · Data updated 2026-11-12
This trial will test whether four weeks of a compound probiotic can improve gastrointestinal function in adults (18–65) with non-organic digestive disorders.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Wecare Probiotics Co., Ltd. Industry-sponsored |
| Locations | 1 site (Suzhou, Jiangsu) |
| Status | Recruiting |
| Started | August 5, 2025 |
| Main results expected | December 30, 2025 |
| Study ends | March 1, 2026 |
| Registry record updated | July 31, 2025 |
| Trial ID | NCT07081100 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with a clinical diagnosis of non-organic gastrointestinal dysfunction, able to give consent and follow the protocol, and not recently using antibiotics or similar products are ideal candidates.
✕Probably not a fit
People with organic gastrointestinal disease, recent or ongoing antibiotic use, allergy to the product, pregnancy or severe systemic illness are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study gives adults with clinically diagnosed non-organic gastrointestinal dysfunction a compound probiotic for four weeks and measures changes in gastrointestinal function. Participants must be 18–65 and free of serious organic disease; common examples include functional dyspepsia and functional constipation. Key exclusions include recent or ongoing antibiotic or probiotic use, pregnancy, allergy to the product, and severe systemic illness. The trial is sponsored by Wecare Probiotics and conducted at Suzhou Ninth Hospital affiliated to Soochow University.
Why it matters
Potential benefit: If successful, the probiotic course could reduce symptoms and improve bowel function for people with functional gastrointestinal disorders.
How similar studies have gone: Previous trials of probiotics for functional gastrointestinal disorders have produced mixed results, with some strains showing modest symptom improvement while others show little effect.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Voluntarily sign the informed consent form and agree to participate in the study. * Ability to complete the study according to the trial protocol requirements. * Aged 18-65 years. * Clinical diagnosis of non-organic gastrointestinal dysfunction (e.g., functional dyspepsia, functional constipation) without other serious organic diseases. Exclusion Criteria: * Use of drugs affecting intestinal flora (antibiotics, probiotics, intestinal mucosal protectants, herbal medicines, etc.) for \>1 week within 1 month prior to screening. * Short-term use of products with functions similar to the investigational product, which may interfere with result interpretation. * Antibiotic use during the study period. * History of severe systemic diseases or malignancies. * Allergy to any ingredient in the compound probiotic freeze-dried powder used in the trial. * Pregnancy, lactation, or plans for pregnancy in the near future. * Inability to participate due to personal reasons. * Other conditions deemed unsuitable by the investigators.
Where it's running
-
Suzhou Ninth People's Hospital Suzhou Ninth Hospital affiliated to Soochow University
Suzhou, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Ying Jin, Doctor
- Email: sunny13211@sina.com
- Phone: 13375163966
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oral Lactulose to Help GI Recovery After Complicated Appendicitis
This trial tests whether giving lactulose by mouth after appendectomy helps people recover bowel function faster than a placebo.
-
Daily Weizmannia (Bacillus) coagulans JBI-YZ6.3 for constipation and gut health in active adults
This test will see if taking a daily Weizmannia (Bacillus) coagulans JBI‑YZ6.3 probiotic improves constipation and other gut symptoms in healthy, physically active adults aged 18–50.
-
Does a daily postbiotic help active adults digest protein better?
This study tests whether taking a daily postbiotic for 12 weeks improves blood levels of essential amino acids after a protein-rich meal in healthy, physically active adults.
-
Probiotics for constipation in adults
This randomized, placebo-controlled study tests whether probiotics can help adults with constipation, compared with a placebo over 8 weeks.
-
Probiotics vs. placebo for adults with constipation
This trial tests whether daily probiotics for 8 weeks help adults with constipation compared with a non-active placebo.
-
Probiotic to ease chronic constipation
This trial will test whether a daily probiotic supplement helps adults with chronic constipation have more regular bowel movements compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.